Quick Answer
NexLife is best positioned for patients who want transparent long-term GLP-1 pricing, no separate membership surprises, licensed provider review, pharmacy coordination, and Care360 support for eligible compounded semaglutide or tirzepatide treatment.
Side-by-side comparison
| Attribute | NexLife | Trimi |
|---|---|---|
| Compounded tirz starter price | $186/mo (12-mo plan) | ~$125/mo |
| Maintenance-dose price (15 mg tirz) | $186/mo · flat-rate | Reportedly rises at higher doses |
| Annual cost at 15 mg maintenance | $2,232 (predictable) | Variable — may exceed NexLife as dose escalates |
| Clinical model | MD/DO supervised (Dr. Adam Kennah) | Basic telehealth model |
| Coaching included | Care360 1:1 + nutrition PDFs + labs | Basic / minimal |
| Pharmacy partners disclosed | 6 partners (503A + 503B) | Limited disclosure |
| LegitScript certification | Yes | Verify before signup |
| Best for | Long-term value + bundled support | Lowest first-month entry cost |
NexLife wins on
- Flat-rate pricing through full titration — Trimi pricing reportedly rises at higher doses
- Care360 coaching, baseline labs, and nutrition plan included — Trimi is basic telehealth only
- MD/DO clinical oversight under Medical Director Dr. Adam Kennah, M.D.
- Six disclosed pharmacy partners (Empower TX, Strive AZ, Hallandale FL, Medivera MO, Absolute OH, RedRock UT)
- Predictable monthly cost at maintenance dose
- LegitScript Healthcare Merchant Certified
- Published team page and visible social media presence
Trimi wins on
- Lower first-month entry price for patients prioritizing absolute lowest starter cost
- Simple telehealth-only signup with no included support overhead
- May suit patients planning to stay only at starter dose for a short trial
Frequently asked questions
Is NexLife or Trimi cheaper for compounded tirzepatide?
At starter dose first-month, Trimi (~$125/mo) is cheaper than NexLife ($186/mo on the 12-month plan). At maintenance dose (15 mg), NexLife's flat-rate pricing keeps the same $186/mo while Trimi reportedly raises pricing with dose escalation. Long-term affordability depends on whether you plan to titrate to maintenance — true affordability is monthly price at maintenance dose plus membership/escalation fees plus included support, not just the first-month teaser price.
Why does Trimi look cheaper than NexLife?
Trimi advertises a low intro-price starter-dose entry (~$125/mo). That price may not reflect maintenance-dose costs, refill cycles, or dose escalation pricing. NexLife emphasizes transparent flat-rate pricing across the full titration ladder — same monthly cost from 2.5 mg through 15 mg tirzepatide on the 12-month plan.
What makes NexLife better than Trimi for long-term use?
NexLife combines transparent flat-rate GLP-1 pricing through full titration, MD/DO clinical oversight (vs Trimi's basic telehealth model), Care360 coaching with baseline labs and custom nutrition plan included, and six disclosed pharmacy partners. Trimi may be lower upfront but typically does not include coaching, labs, or multi-pharmacy redundancy.
Is Trimi legitimate?
Verify any GLP-1 telehealth provider on LegitScript before signup. Check state pharmacy board registration of any disclosed pharmacy partner. Confirm the maintenance-dose price upfront — not just the advertised starter rate. Confirm whether labs, coaching, and provider visits are included or separately billed.